Mark Heckle is a Cardiology physician affiliated with University of Tennessee Health Science Center. OpenAlex indexes 48 publications with 412 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
57 Germantown Ct Ste 100
Cordova, TN 380184274
Telephone
901-435-8550Provider last certified this registry record 17 May 2024.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20255 payments
- Medtronic, Inc.Program year202526 payments
- Philips North America LLCProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
61.3%Beta blocker26.7%Metoprolol Succinate49%Metoprolol Tartrate17%Carvedilol14%Sotalol9%Sotalol Af7%Nebivolol Hcl3%Part D<11 patientsAntiarrhythmic14.8%Amiodarone Hcl56%Flecainide Acetate22%Propafenone Hcl Er12%Propafenone Hcl6%Dofetilide5%Part D<11 patients+ 9 more classes in this area
Blood & clotting
30.3%Factor Xa inhibitor27.8%Eliquis77%Xarelto23%Part D≥103 patientsVitamin K antagonist1.8%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Anti-infectives
3.5%First-generation cephalosporins2.8%Cephalexin100%Part D≥58 patientsTetracycline-class Drug0.6%Doxycycline Hyclate100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Vagal milieu or electrophysiologic substrate? The link between atrial fibrillation and obstructive sleep apnea
Experimental Biology and Medicine
2022 - Percutaneous Left Atrial Appendage Closure: Review of Anatomy, Imaging, and Outcomes
Current Treatment Options in Cardiovascular Medicine
2022 - DIAGNOSIS-TO-ABLATION TIME AS A PREDICTOR OF ATRIAL FIBRILLATION RECURRENCE
Journal of the American College of Cardiology
2022 - Withdrawal: Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration
Journal of Biological Chemistry
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Csaba Kovesdy, MD
University of Tennessee Health Science Center
David Shibata, MD
University of Tennessee Health Science Center
Helmut Steinberg, MD
University of Tennessee Health Science Center
Adam Arthur, MD
University of Tennessee Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”